Propafenone
| Clinical data | |
|---|---|
| Pronunciation | /proʊˈpæfɪnoʊn/ proh-PAF-i-nohn | 
| Trade names | Rythmol, Rytmonorm, others | 
| AHFS/Drugs.com | Monograph | 
| MedlinePlus | a698002 | 
| License data | 
 | 
| Routes of administration | By mouth | 
| ATC code | |
| Legal status | |
| Legal status | 
 | 
| Pharmacokinetic data | |
| Protein binding | 97% | 
| Elimination half-life | 2–10 hours | 
| Identifiers | |
| 
 | |
| CAS Number | |
| PubChem CID | |
| IUPHAR/BPS | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.053.578 | 
| Chemical and physical data | |
| Formula | C21H27NO3 | 
| Molar mass | 341.451 g·mol−1 | 
| 3D model (JSmol) | |
| 
 | |
| 
 | |
| (verify) | |
Propafenone, sold under the brand name Rythmol among others, is a class 1c anti-arrhythmic medication, which is used to treat illnesses associated with rapid heart beat such as atrial and ventricular arrhythmias.